Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12759]

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

FDA approves new dosing regimen for pembrolizumab

FDA approves new dosing regimen for pembrolizumab

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with cabozantinib in previously untreated advanced renal cell carcinoma

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with...

Positive results from pivotal phase 3 trial evaluating nivolumab plus ipilimumab vs chemotherapy in previously untreated malignant pleural mesothelioma

Positive results from pivotal phase 3 trial evaluating nivolumab plus ipilimumab vs chemotherapy in previously...

Are older adults getting the most effective cancer treatments?

Are older adults getting the most effective cancer treatments?

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

A promising new treatment for recurrent paediatric brain cancer

A promising new treatment for recurrent paediatric brain cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

Major trial shows breast cancer drug can hit prostate cancer Achilles heel

Major trial shows breast cancer drug can hit prostate cancer Achilles heel

AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers

AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers

More from ecancer